HHMI
CE icon

Howard Hughes Medical Institute’s Celanese CE Stock Holding History

Howard Hughes Medical Institute’s Portfolio CE Stock Details CE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,447
Closed -$80K – 186
2014
Q1 		$80K Sell
1,447
-302
-17% -$16.1K 0.01% 130
2013
Q4 		$97K Buy
1,749
+786
+82% +$43.6K 0.01% 132
2013
Q3 		$51K Sell
963
-481
-33% -$23.6K 0.01% 158
2013
Q2 		$65K Buy
+1,444
New +$67.9K 0.02% 152

Other funds holding CE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Howard Hughes Medical Institute's CE Position: Q2 2014 in Review

Howard Hughes Medical Institute sold out of Celanese (CE) in Q2 2014, closing a stake of 1,447 shares — an estimated $80K sold.

Howard Hughes Medical Institute first reported a position in CE in Q2 2013 and held it in 4 quarters. The position peaked at $97K in Q4 2013. 340 funds tracked by Wall St. Rank hold CE as of Q2 2014.

  • Howard Hughes Medical Institute reported no remaining Celanese position as of Q2 2014 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 1,447 Celanese shares in Q2 2014, an estimated $80K.
  • Howard Hughes Medical Institute first reported a position in Celanese in Q2 2013 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Celanese position peaked at $97K in Q4 2013.
  • 340 funds tracked by Wall St. Rank held Celanese as of Q2 2014.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2014, filed 1 Aug 2014.